Arcutis Biotherapeutics, Inc. (ARQT)
24.78
-2.19
(-8.12%)
USD |
NASDAQ |
Mar 02, 16:00
24.69
-0.09
(-0.36%)
After-Hours: 17:13
Arcutis Biotherapeutics EPS Diluted (Quarterly) : 0.1282 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CorMedix, Inc. | 1.259 |
| ADMA Biologics, Inc. | 0.2025 |
| ANI Pharmaceuticals, Inc. | 1.172 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 17.40M |
| Revenue (Quarterly) | 129.50M |
| Total Expenses (Quarterly) | 112.11M |
| Enterprise Value | 3.197B |
| Gross Profit Margin (Quarterly) | 90.97% |
| Profit Margin (Quarterly) | 13.43% |
| Earnings Yield | -0.56% |
| Normalized Earnings Yield | -0.5711 |